BOLERO1_2B: BOLERO1, figure 2B

BOLERO1_2BR Documentation

BOLERO1, figure 2B

Description

Kaplan-Meier digitized data from BOLERO1, figure 2B (PMID 26092818). A reported sample size of 719 for a primary endpoint of PFS(overall & HR- population) in breast cancer.

Usage

BOLERO1_2B

Format

A data frame of 719 observations and 3 variables:

time event time (in months)
event PFS event indicator (0: no event, 1: event)
arm treatment arms (everolimus, placebo)

Source

Hurvitz SA, Andre F, Jiang Z, et al. Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial. Lancet Oncol 2015; 16: 816–29.

Examples

summary(BOLERO1_2B)

kmplot(BOLERO1_2B)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.